PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))

Term ID

CHEBI:89084

Synonyms

(2-{[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Eicosadienoyl-2-g-linolenoyl-sn-glycero-3-phosphocholine
1-Eicosadienoyl-2-gamma-linolenoyl-sn-glycero-3-phosphocholine
GPCho(20:2/18:3)
GPCho(20:2n6/18:3n6)
GPCho(20:2w6/18:3w6)
GPCho(38:5)
Lecithin
PC aa C38:5
PC(20:2/18:3)
PC(20:2n6/18:3n6)
PC(20:2w6/18:3w6)
PC(38:5)
Phosphatidylcholine(20:2/18:3)
Phosphatidylcholine(20:2n6/18:3n6)
Phosphatidylcholine(20:2w6/18:3w6)
Phosphatidylcholine(38:5)

(all 17)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))

Phenotype where environments contain PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))

Phenotype modified by environments containing PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))

Phenotype affecting PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))

Human Disease Model